Sana Biotechnology Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Sana Biotechnology, Inc. (SANA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-266.76-283.26-269.48-355.93-285.31
Depreciation & Amortization15.5024.5615.6311.075.92
Stock Based Compensation37.6835.5338.3422.365.83
Change in Working Capital-1.1918.617.549.806.16
Change in Accounts Payable1.381.031.06-0.271.98
Change in Other Working Capital-2.56-49.036.4861.644.17
Other Operating Activities-10.28-49.03-82.0861.64129.42
Net Cash from Operating Activities-223.15-253.58-290.05-251.05-137.98
Investing Activities
Capital Expenditures-33.43-20.03-20.88-29.86-23.87
Acquisitions0.00-40.77-3.3631.840.00
Purchases of Investments50.88-157.74231.44-491.39-228.69
Sales/Maturities of Investments0.00349.79231.44280.03-228.69
Other Investing Activities17.450.000.00-4.570.00
Net Cash from Investing Activities17.45172.01210.56-245.80-252.56
Financing Activities
Debt Repayment7.740.000.000.000.00
Common Stock Issued192.0127.024.91631.75435.54
Other Financing Activities11.010.000.000.000.00
Net Cash from Financing Activities199.7531.654.91631.75435.69
Summary
Net Change in Cash-5.95-49.92-74.58134.9045.14
Cash at Beginning of Period137.35187.27261.85126.9581.81
Cash at End of Period131.40137.35187.27261.85126.95
Free Cash Flow-256.58-273.61-310.93-280.92-161.85